ACN Q1 2026 Earnings EPS Beats Estimates by 213 Amid Consulting Demand KALV Q1 2026 Earnings Narrower Loss Beats Expectations Clinical Pipeline Progress Underway OCUL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Development VNO Q1 2026 Earnings EPS Misses as Office Headwinds Persist NWN Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development